[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Page 38087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-15617]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; ISP 
Inc.

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 30, 2012, ISP Inc., 238 
South Main Street, Assonet, Massachusetts 02702, made application by 
renewal to the Drug Enforcement Administration (DEA) as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............  I
Amphetamine (1100).........................  II
Phenylacetone (8501).......................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk API, for distribution to its 
customers. The bulk 2,5-Dimethoxyamphetamine will be used for 
conversion into non-controlled substances.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 27, 2012.

    Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-15617 Filed 6-25-12; 8:45 am]
BILLING CODE 4410-09-P